Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
NCT06342284 is an observational study sponsored by The New York Proton Center. As of 21 Nov 2026, it is recruiting participants. It studies Thoracic Cancer. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 22 Mar 2024 and a primary completion date of 31 Mar 2028. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT06342284 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | The New York Proton Center |
| Enrollment | 40 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Thoracic Cancer |
| Start | 22 Mar 2024 |
| Primary completion | 31 Mar 2028 |
| Study completion | 21 Mar 2031 |
| Last update posted | 13 Apr 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- New York Proton Center
New York
Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT06342284
Each answer restates registry values shown on this page.
What is NCT06342284?
NCT06342284 is an observational study sponsored by The New York Proton Center. It studies Thoracic Cancer.
Is NCT06342284 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT06342284?
The registry names Nitin Ohri, MD (principal investigator, Montefiore Medical Center) as the overall official.
Where does NCT06342284 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT06342284 expected to complete?
The registry lists a primary completion date of 31 Mar 2028 and a study completion date of 21 Mar 2031. The sponsor last updated the record on 13 Apr 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.